Medtronic has completed the acquisition of CathWorks, a company specialising in advancing the diagnosis and treatment of CAD, for $585m.

OEMs continue to prioritise high-growth segments of the medtech industry such as pulsed-field ablation (PFA), while conflict in the Middle East is impacting IPO activity.

Pulnovo Medical has completed an oversubscribed $100m strategic financing round, with Medtronic as the lead investor.

ScreenPoint’s Transpara AI is integrated with Siemens Healthineers tools, including syngo.Breast Care and its MAMMOMAT range.

The Bruker Microbiology & Infection Diagnostics division has announced the European launch of its MyGenius PRO automated S2A molecular diagnostics system at the ESCMID Global 2026.

Philips has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Verida spectral CT system.

Validated biomarkers help physicians identify patients that will benefit most from certain treatments, but implementation challenges remain.

J&J has reported interim 12-month results from the VARIPURE study, assessing the effectiveness and safety of its Varipulse PFA platform in first-time users.

Avanos Medical is to be acquired by affiliates of AIP in an all-cash transaction that values the company at an enterprise value of $1.27bn.

Heartflow alleges that after working as its consultant, Cleerly’s CEO launched a competing enterprise “built upon” Heartflow’s innovations.

Amplitude Vascular’s lead development product is an intravascular lithotripsy platform for calcified peripheral artery disease treatment.

Phantom Neuro has secured approval to initiate a trial of its minimally invasive muscle-machine interface in Australia.